BNGO - Bionano Announces the Final Speaker Lineup for 2024 Symposium with 33 OGM Presentations and Live Panel Discussions Across a Wide Range of Research Applications | Benzinga
- 26 different customers representing North America, Asia and Europe
- 33 oral presentations across four consecutive days
- 69 scientific posters will be featured in a virtual exhibition hall
- Topics span the application of optical genome mapping (OGM) in research applications in cancer, cell and gene therapy, and genetic diseases
SAN DIEGO, Jan. 19, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc (NASDAQ:BNGO) today announced its 2024 Symposium lineup of 33 oral presentations delivered by 26 different customers worldwide featuring the utility of optical genome mapping (OGM) across a wide range of research applications in cancer, cell and gene therapy, and genetic disease. 2024 Symposium will take place virtually from January 22 to 25, 2024. During these four days, customers will showcase their latest research findings using OGM. Each day will feature user presentations, a live panel with Q&A, and scientific posters within the virtual exhibition hall. On day 2, Bionano will unveil a new product expected to advance cytogenetics and structural variant analysis.
"We believe 2024 Symposium is an opportunity for the OGM community to come together and share the progress they are making in translational research using OGM alongside other genome analysis tools," said Erik Holmlin, PhD, president and chief executive officer of Bionano Genomics. "Symposium provides a chance for anyone interested or currently working with OGM to form connections within the community and see the potential impact of looking at the genome in a different way. We believe this year's event will be our best to date, with an expanded focus on the use of OGM in cell and gene therapy, as well as some very exciting product announcements that will drive further research advancements."
"Our 2023 Symposium was a fantastic event where OGM users shared their data covering genetic disorder and cancer research. Since then, we have made significant improvements in our end-to-end workflow which we believe has enabled our customers to advance their clinical and translational research. The presentations at this year's event have been elevated to a new level, with dedicated sessions on advancements in heme malignancy research and solid tumor analysis, updates from global consortia driving OGM adoption, and new OGM data from researchers focused on solving constitutional diseases and rare disease," said Alka Chaubey, PhD, FACMG, chief medical officer at Bionano. "Symposium attendees have a unique opportunity to learn from their peers, network, and view scientific posters and new products that we will showcase each day."
Each session of Symposium will start at 7:00 am PST and will last approximately 3 hours. After the scientific presentations, the speakers will join for a live panel discussion and Q&A moderated by Dr. Chaubey. In addition, each day will feature a scientific poster exhibit. Below is the list of customer presentations for each day and the application area.
January 22: New Standards in Hematological Malignancies
Speaker |
Institution |
Title |
Dr. Tiffany Clouston |
Saint John Regional Hospital |
Optical Genome Mapping: Pivoting Towards a New Technology |
Dr. Ying Zou |
Johns Hopkins University School of Medicine |
Comprehensive Genome-wide Genetic Profile in Plasma Cell Neoplasm by OGM |
Dr. Guilin Tang |
University of Texas MD Anderson Cancer Center |
Optical Genome Mapping (OGM) in T-lymphoblastic Leukemia (T-ALL) |
Dr. Yanming Zhang |
Memorial Sloan Kettering Cancer Center |
Clinical Research Applications of Optical Genome Mapping (OGM) in Cancer Cytogenetics |
Dr. Agnes Daudignon |
Lille Hospital |
FrOGG: French Speaking OGM Group from GFCH |
Dr. Adam Smith |
University of Toronto |
The "Framework" for the Clinical Research Implementation of Optical Genome Mapping in Hematologic Malignancies |
Daniel Saul |
Bionano |
Advancements in Informatics and Software for OGM Data Analysis |
January 23: New Frontiers in Oncology
Speaker |
Institution |
Title |
Dr. Marc-Henri Stern |
Institut Curie |
Features of Homologous ... |